Vacancy announcement | September 16, 2025
Hayat Hospital Medical College is the pioneer private hospital providing comprehensive health care services. Our Hospital wants to recruit competent health professionals in vacant positions listed below in the hospital.
The detail of the vacancies and requirements are as follows;
1. Clinical Nurse
Qualification – BSC in Clinical Nursing
Number – 02
Experience – 1 year and above
2. Pharmacist
Qualification – Bachelor of clinical pharmacy (B.Pharm)
Number – 03
Experience – 1 year and above
3. ICU Nurse
Qualification – BSC in critical care or BSC in Clinical Nursing
Number – 02
Experience – 1 year and above
4. Receptionist
Qualifications: Diploma and above in information technology or management related fields.
Number: 03
Experience: 1 year and above in hospitality
5. Secretary
Qualifications: Diploma and above in Secretariat science or related fields.
Number : 02
Experience: 1 year and above in secretary, hospital experience is preferable.
Duration of vacancy: 5 Working days for all positions from the day of advertisement.
Salary: negotiable for all positions.
Submit your CV to Hayat Hospital Administration during working hours from 8:30am – 5:00pm.
Hayat Hospital Medical College PLC
@HakimEthio
Hayat Hospital Medical College is the pioneer private hospital providing comprehensive health care services. Our Hospital wants to recruit competent health professionals in vacant positions listed below in the hospital.
The detail of the vacancies and requirements are as follows;
1. Clinical Nurse
Qualification – BSC in Clinical Nursing
Number – 02
Experience – 1 year and above
2. Pharmacist
Qualification – Bachelor of clinical pharmacy (B.Pharm)
Number – 03
Experience – 1 year and above
3. ICU Nurse
Qualification – BSC in critical care or BSC in Clinical Nursing
Number – 02
Experience – 1 year and above
4. Receptionist
Qualifications: Diploma and above in information technology or management related fields.
Number: 03
Experience: 1 year and above in hospitality
5. Secretary
Qualifications: Diploma and above in Secretariat science or related fields.
Number : 02
Experience: 1 year and above in secretary, hospital experience is preferable.
Duration of vacancy: 5 Working days for all positions from the day of advertisement.
Salary: negotiable for all positions.
Submit your CV to Hayat Hospital Administration during working hours from 8:30am – 5:00pm.
Hayat Hospital Medical College PLC
@HakimEthio
❤13👍1
🧠💉 Depo-Provera Linked to Meningioma Risk: What Clinicians and Patients Need to Know (JAMA Neurology, Sept 2025)
✅A U.S. study in JAMA Neurology (Xiao et al., 2025) uncovers a link between Depot Medroxyprogesterone Acetate (DMPA, Depo-Provera) and meningioma risk, guiding clinical practice and patient counseling.
🔍 Study Overview
- Design: Retrospective cohort study of 61 million women (TriNetX database).
- Goal: Assess meningioma risk with DMPA and other contraceptives.
- Outcome: Meningioma diagnosis.
📊 Key Findings
👉 DMPA: Relative Risk (RR) = 2.43 (95% CI, 1.77–3.33); Number Needed to Harm (NNH) = 1152.
👉Highest Risk in:
🩵 Women using DMPA for >4 years.
🩵Women starting DMPA after age 31
👉💊 Oral MPA: RR = 1.18 (95% CI, 1.10–1.27); NNH = 3020.
✅ Other Contraceptives: No risk increase for Combined Oral Contraceptives, Levonorgestrel IUDs, Progestin-Only Pills, or Subdermal Implants.
🌍 Context
👉Aligns with European studies (2018–2023) showing 2–7× meningioma risk with high-dose progestins, with tumor regression possible after discontinuation.
👉 Europe’s response included warnings and lawsuits, signaling U.S. medico-legal risks.
🩺 Clinical Takeaways
1. 🗣️ Counsel Clearly: DMPA doubles meningioma risk (1 extra case per ~1150 women). Highlight low absolute risk.
2. 🧑⚕️ Personalize Care: Reconsider long-term DMPA (>4 years) in women over 30 or with meningioma history, NF2, or cranial irradiation.
3. 🔄 Safer Options: Suggest LNG-IUD, progestin implants, or COCPs, which show no meningioma risk.
4. 👀 Stay Alert: Investigate neurological symptoms (e.g., headaches, vision changes) with exams or MRI; consider stopping DMPA if meningioma is found.
⚖️ Medico-Legal Note
France’s lawsuits against progestin manufacturers stress documenting informed consent. U.S. providers should discuss risks and alternatives to reduce liability.
🎯 Bottom Line
👉DMPA’s meningioma risk is small but notable for long-term users or those over 30.
👉Counsel precisely, screen high-risk patients, offer alternatives, and document discussions.
👉DMPA remains valuable with informed choices.
📚 Source: Xiao et al., JAMA Neurology, September 2025
Dr.Abera Etana / Internal Medicine Resident
#MedEd #OBGYN #Neurology #FamilyMedicine #WomensHealth #Contraception #Meningioma #DMPA #PatientSafety #SharedDecisionMaking #ABE
@HakimEthio
✅A U.S. study in JAMA Neurology (Xiao et al., 2025) uncovers a link between Depot Medroxyprogesterone Acetate (DMPA, Depo-Provera) and meningioma risk, guiding clinical practice and patient counseling.
🔍 Study Overview
- Design: Retrospective cohort study of 61 million women (TriNetX database).
- Goal: Assess meningioma risk with DMPA and other contraceptives.
- Outcome: Meningioma diagnosis.
📊 Key Findings
👉 DMPA: Relative Risk (RR) = 2.43 (95% CI, 1.77–3.33); Number Needed to Harm (NNH) = 1152.
👉Highest Risk in:
🩵 Women using DMPA for >4 years.
🩵Women starting DMPA after age 31
👉💊 Oral MPA: RR = 1.18 (95% CI, 1.10–1.27); NNH = 3020.
✅ Other Contraceptives: No risk increase for Combined Oral Contraceptives, Levonorgestrel IUDs, Progestin-Only Pills, or Subdermal Implants.
🌍 Context
👉Aligns with European studies (2018–2023) showing 2–7× meningioma risk with high-dose progestins, with tumor regression possible after discontinuation.
👉 Europe’s response included warnings and lawsuits, signaling U.S. medico-legal risks.
🩺 Clinical Takeaways
1. 🗣️ Counsel Clearly: DMPA doubles meningioma risk (1 extra case per ~1150 women). Highlight low absolute risk.
2. 🧑⚕️ Personalize Care: Reconsider long-term DMPA (>4 years) in women over 30 or with meningioma history, NF2, or cranial irradiation.
3. 🔄 Safer Options: Suggest LNG-IUD, progestin implants, or COCPs, which show no meningioma risk.
4. 👀 Stay Alert: Investigate neurological symptoms (e.g., headaches, vision changes) with exams or MRI; consider stopping DMPA if meningioma is found.
⚖️ Medico-Legal Note
France’s lawsuits against progestin manufacturers stress documenting informed consent. U.S. providers should discuss risks and alternatives to reduce liability.
🎯 Bottom Line
👉DMPA’s meningioma risk is small but notable for long-term users or those over 30.
👉Counsel precisely, screen high-risk patients, offer alternatives, and document discussions.
👉DMPA remains valuable with informed choices.
📚 Source: Xiao et al., JAMA Neurology, September 2025
Dr.Abera Etana / Internal Medicine Resident
#MedEd #OBGYN #Neurology #FamilyMedicine #WomensHealth #Contraception #Meningioma #DMPA #PatientSafety #SharedDecisionMaking #ABE
@HakimEthio
❤35👍10
ሃይድሮሴፋለስ | Hydrocephalus
ሃይድሮሴፋለስ (በአማርኛ አቻ ትርጉም አላገኘሁለትም): የአንጎል አና ህብለሰረሰር ፈሳሽ ኡደት መዛባት ተከትሎ የሚመጣ የፈሳሽ መከማቸት ሲሆን ይህም በአንጎል ላይ ግፊት አና ጫና በማምጣት በዙዎችን ለሞት የዳረገ ህመም ነው::
በህፃናት አና በ አዋቂዎች አመጣጡ አና የሚያሳየው ባህሪ ይለያያል:: የህፃናት የራስ ቅል በቶሎ ስለማይገጥም ግፊቱ ሲጨምር በማደግ ትልቅ ጭንቅላት ይኖራቸዋል::
የፈሳሹ መከማቸት አንጎሉን ከራስ ቅል ጋር ስለሚጫነው አድገታቸው ዘገምተኛ ይሆናል:: ይህም ማለት ራሳቸዉን ችለው መቀመጥ በሚገባቸው ሰዓት ያንን ማድረግ ያዳግታቸዋል:: መናገር የሚገባቸዉን ያክል መናገር ይቸገራሉ:: ቀስበቀስ እይታቸው ሊጠፋ ይችላል:: አለፍ ሲል ደግሞ ለሞት ይዳርጋል ::
የራስ ቅል ከገጠመ በሁዋላ (በመሃል አናት ትር ትር የሚለው ሲጠፋ) የፈሳሹ ግፊት በቶሎ ስለሚጨምር በጣም ድንገተኛ እና ካልታከመ ለሞት ይዳርጋል::
በአብዛኛው በህፃናት የሚከሰትበት ምክንያት በተፈጥሮ ሲሆን ተያያዥ የነርቭ ዘንግ ከፍተት ችግር ሊኖራቸው ይችላል:: የጨቅላ ሕፃን እንፈክሽን ተከትሎ ሊመጣ ይችላል:: ሌላኛው አና በቶሎ መታከም የሚገባው የህፃናት አንጎል እጥኢ(Brain tumor) ተከትሎ የሚመጣ ሲሆን ነው::
ሕክምናዉም የ ፈሳሹን መስመር ማስተካከል ሲሆን
1: በቱቦ (shunt catheter )ከ አንጎል ወደ ሆድ (Peritoneal space)ወይም ወደ ሌላ ክፍል (pleura or atrium) እንዲፈስ ይደረጋል:: ቱቦው ከቆዳ ስር የሚያልፍ ሲሆን በዙዉን ጊዜ አድሜ ሙሉ የሚቆይ ነው::
2: በ ኢንዶስኮፕ (Endoscopic ventriculostomy) የፈሳሹን መስመር መክፈት
3: መስመሩን የዘጋዉን ዕጢ በ ቀዶ ጥገና ማስወገድ
4: ግዜያዊ ማስተገሻ መድኃኒቶችን መጠቀም
5: አንዳንዴ ፈሳሹ ወደ ዉጭ በተዘጋጀለት ማጠራቀሚያ እንዲፈስ ማድረግ እና ሌሎችም::
ይህ መታከም የሚቺል ችግር የብዙዎችን ሕይወት እየቀጠፈ እና የአእምሮ አድገት ዘገም አንዲል ያደርጋል:: ሁላችንም ይመለከታልና የበኩላችን እንወጣ::
References
1. Mulugeta B, Seyoum G, Mekonnen A, Ketema E. Assessment of the prevalence and associated risk factors of pediatric hydrocephalus in diagnostic centers in Addis Ababa, Ethiopia. BMC Pediatr. 2022 Mar 18;22(1):145. doi: 10.1186/s12887-022-03212-6. PMID: 35303805; PMCID: PMC8932009.
2. Hochstetler, A., Raskin, J. & Blazer-Yost, B.L. Hydrocephalus: historical analysis and considerations for treatment. Eur J Med Res 27, 168 (2022). https://doi.org/10.1186/s40001-022-00798-6
September is hydrocephalus awareness month.
ዶ/ር ሱራፌል መኮንን: የአንጎል ህብለሰረሰር ቀዶ ጥገና ስፔሺያሊስት: Pediatric Neurosurgery Fellow)
Istanbul, Turkey
@HakimEthio
ሃይድሮሴፋለስ (በአማርኛ አቻ ትርጉም አላገኘሁለትም): የአንጎል አና ህብለሰረሰር ፈሳሽ ኡደት መዛባት ተከትሎ የሚመጣ የፈሳሽ መከማቸት ሲሆን ይህም በአንጎል ላይ ግፊት አና ጫና በማምጣት በዙዎችን ለሞት የዳረገ ህመም ነው::
በህፃናት አና በ አዋቂዎች አመጣጡ አና የሚያሳየው ባህሪ ይለያያል:: የህፃናት የራስ ቅል በቶሎ ስለማይገጥም ግፊቱ ሲጨምር በማደግ ትልቅ ጭንቅላት ይኖራቸዋል::
የፈሳሹ መከማቸት አንጎሉን ከራስ ቅል ጋር ስለሚጫነው አድገታቸው ዘገምተኛ ይሆናል:: ይህም ማለት ራሳቸዉን ችለው መቀመጥ በሚገባቸው ሰዓት ያንን ማድረግ ያዳግታቸዋል:: መናገር የሚገባቸዉን ያክል መናገር ይቸገራሉ:: ቀስበቀስ እይታቸው ሊጠፋ ይችላል:: አለፍ ሲል ደግሞ ለሞት ይዳርጋል ::
የራስ ቅል ከገጠመ በሁዋላ (በመሃል አናት ትር ትር የሚለው ሲጠፋ) የፈሳሹ ግፊት በቶሎ ስለሚጨምር በጣም ድንገተኛ እና ካልታከመ ለሞት ይዳርጋል::
በአብዛኛው በህፃናት የሚከሰትበት ምክንያት በተፈጥሮ ሲሆን ተያያዥ የነርቭ ዘንግ ከፍተት ችግር ሊኖራቸው ይችላል:: የጨቅላ ሕፃን እንፈክሽን ተከትሎ ሊመጣ ይችላል:: ሌላኛው አና በቶሎ መታከም የሚገባው የህፃናት አንጎል እጥኢ(Brain tumor) ተከትሎ የሚመጣ ሲሆን ነው::
ሕክምናዉም የ ፈሳሹን መስመር ማስተካከል ሲሆን
1: በቱቦ (shunt catheter )ከ አንጎል ወደ ሆድ (Peritoneal space)ወይም ወደ ሌላ ክፍል (pleura or atrium) እንዲፈስ ይደረጋል:: ቱቦው ከቆዳ ስር የሚያልፍ ሲሆን በዙዉን ጊዜ አድሜ ሙሉ የሚቆይ ነው::
2: በ ኢንዶስኮፕ (Endoscopic ventriculostomy) የፈሳሹን መስመር መክፈት
3: መስመሩን የዘጋዉን ዕጢ በ ቀዶ ጥገና ማስወገድ
4: ግዜያዊ ማስተገሻ መድኃኒቶችን መጠቀም
5: አንዳንዴ ፈሳሹ ወደ ዉጭ በተዘጋጀለት ማጠራቀሚያ እንዲፈስ ማድረግ እና ሌሎችም::
ይህ መታከም የሚቺል ችግር የብዙዎችን ሕይወት እየቀጠፈ እና የአእምሮ አድገት ዘገም አንዲል ያደርጋል:: ሁላችንም ይመለከታልና የበኩላችን እንወጣ::
References
1. Mulugeta B, Seyoum G, Mekonnen A, Ketema E. Assessment of the prevalence and associated risk factors of pediatric hydrocephalus in diagnostic centers in Addis Ababa, Ethiopia. BMC Pediatr. 2022 Mar 18;22(1):145. doi: 10.1186/s12887-022-03212-6. PMID: 35303805; PMCID: PMC8932009.
2. Hochstetler, A., Raskin, J. & Blazer-Yost, B.L. Hydrocephalus: historical analysis and considerations for treatment. Eur J Med Res 27, 168 (2022). https://doi.org/10.1186/s40001-022-00798-6
September is hydrocephalus awareness month.
ዶ/ር ሱራፌል መኮንን: የአንጎል ህብለሰረሰር ቀዶ ጥገና ስፔሺያሊስት: Pediatric Neurosurgery Fellow)
Istanbul, Turkey
@HakimEthio
❤16👍2